You are here

Lipid & Metabolic

 

The 2016 National Survey of Children’s Health revealed 31.2 percent of American children age 10-17 are either overweight or obese.

Empagliflozin tablets reduced the risk of cardiovascular death by 38 percent in people with type 2 diabetes and established cardiovascular disease (CVD), according to a randomized, placebo-controlled trial of more than 7,000 patients. And new analyses demonstrate a similar benefit was seen in all patients, regardless of blood sugar levels at baseline or after the introduction of background treatment.

Children exposed to toxic dust after the attack on New York's World Trade Centers in 2001 are showing early signs of cardiovascular risks, a study suggests.

Apparently, it’s possible to have too much of a good thing. At least that’s what researchers are suggesting about high-density lipoprotein (HDL) cholesterol, widely known as the “good” type of cholesterol.

The diabetes drug liraglutide (Victoza) secured an indication from the FDA to reduce the risk of major adverse cardiovascular (CV) events in adults with Type 2 diabetes and established cardiovascular disease, Novo Nordisk announced Aug. 25.

 

Recent Headlines

Survey: 31% of U.S. children are overweight or obese

The 2016 National Survey of Children’s Health revealed 31.2 percent of American children age 10-17 are either overweight or obese.

Weekly exenatide injections have no impact on cardiovascular outcome in diabetics

After testing a once-weekly injectable form of glucose-lowering drug exenatide on type 2 diabetes patients for years, researchers have concluded the medication doesn’t have any effect on the incidence of major cardiovascular events.

11% of older diabetes patients dangerously overtreated

Overtreatment of diabetes in elderly patients could be contributing to an increase in the number of falls, dizzy spells and confusion those individuals experience, according to research published in the Journal of General Internal Medicine.

'Sitting is the new smoking': Sedentary behavior linked to increased all-cause mortality

For years, medical professionals and media personalities alike have warned against sitting for prolonged periods, coining the phrase "sitting is the new smoking" to describe the health risks of a sedentary lifestyle. But how much is too much?

Scientists link obstructive sleep apnea, cardiometabolic dysfunction

A group of Johns Hopkins scientists have uncovered a link between sleep apnea and cardiometabolic dysfunction that could help explain heart disease in sleep patients, according to a recent study.

Type 2 diabetes medicine cuts risk of CV death independent of background blood sugar control

Empagliflozin tablets reduced the risk of cardiovascular death by 38 percent in people with type 2 diabetes and established cardiovascular disease (CVD), according to a randomized, placebo-controlled trial of more than 7,000 patients. And new analyses demonstrate a similar benefit was seen in all patients, regardless of blood sugar levels at baseline or after the introduction of background treatment.

Research links socioeconomic stress to metabolic syndrome in black youth

Socioeconomic stress could have a major impact on black young adults’ heart health, according to a new study published in the Journal of the American Heart Association.

Metabolically healthy obese individuals still at increased risk for heart disease

After spending nearly six years researching the relationship between metabolically healthy obesity and risk of cardiovascular disease, a team of U.K. doctors are suggesting that even “healthy” obese individuals are more prone to develop heart issues.

Children exposed to toxic dust after 9/11 show signs of heart disease

Children exposed to toxic dust after the attack on New York's World Trade Centers in 2001 are showing early signs of cardiovascular risks, a study suggests.

'Good' cholesterol not so great in extreme cases

Apparently, it’s possible to have too much of a good thing. At least that’s what researchers are suggesting about high-density lipoprotein (HDL) cholesterol, widely known as the “good” type of cholesterol.

Pages